15 years of Nature Nanotechnology

On the occasion of the anniversary, we look back at 15 years of great nanoscience and nanotechology. 


  • Picture of authors

    20th October 2021, 3.15 pm BST. We celebrate 15 years of Nature Nanotechnology with a series of webinar with experts in research at the nanoscale. In this first webinar we are joined by Prof. Ben Feringa and Prof. Robert Langer. Please register for the correct date.

  • Webinars banner

    To celebrate the 15th anniversary of Nature Nanotechnology we are joined by experts in various areas of research at the nanoscale in a series of webinars running from 20th October to 1st December. register for each webinar individually.

  • conference image

    In this forum we shall explore with experts the most recent progress in the clean water production technologies suitable for small scale and decentralized applications, e.g. nanofiltration, solar evaporation and distillation, atmospheric water harvesting. We shall also discuss the innovation and policy challenges that need to be overcome for the successful implementations of such technologies.

  • banner

    Join Nature Nano and a number of experts to discuss exciting topics in nanotechnology.

    Coming up:

    Nature Nano Talks - Nanotechnology and Global Health - A panel discussion 21st April, 3 pm UK time

Nature Nanotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


  • The effective absorption spectrum of metal-bound molecules and a rich plasmon-driven chemistry landscape are constructed by monitoring the interfacial environment of a thousand single nanocavities with slightly varied resonance energies.

    • Eitan Oksenberg
    • Ilan Shlesinger
    • Erik C. Garnett
  • The stimulation of interferon genes (STING) pathway with STING agonists such as cyclic dinucleotides (CDNs) has emerged as a promising immunotherapeutic approach. Here, the authors show that Mn2+ can amplify the STING-promoted anti-tumour immune response in challenging murine tumour models by coordinating with CDNs and self-assembling into nanoparticles that can be delivered locally and systemically.

    • Xiaoqi Sun
    • Yu Zhang
    • James J. Moon
  • Type I interferons (IFNs) have strong antitumour activity yet their clinical use is limited by their off-target toxicity and by their effect on immune evasion. Here the authors design a biomimetic nanoparticle loaded with an IFN inducer, which can at the same time replenish intratumoural IFNs and reduce their immunosuppressive activity, showing therapeutic efficacy in several animal tumour models.

    • Yihui Zhai
    • Jinming Wang
    • Yaping Li
  • Gas vesicles are air-filled protein nanostructures naturally expressed by certain bacteria and archaea to achieve cellular buoyancy. Here the authors show that, under the stimulation of pulsed ultrasound, targeted gas vesicles and gas vesicles expressed in genetically modified bacteria and mammalian cells release nanobubbles that, collapsing, lead to controlled mechanical damage of the surrounding biological milieu, demonstrating that, under focused ultrasound actuation, gas vesicles have potential applications as therapeutic agents.

    • Avinoam Bar-Zion
    • Atousa Nourmahnad
    • Mikhail G. Shapiro
  • We celebrate the fifteenth anniversary of Nature Nanotechnology by looking at how the journal topics have expanded throughout the years.

  • Almost all currently used vaccines against COVID-19 consist of either non-viral or viral nanoparticles. Here we attempt to understand the reasons behind the success of such advanced nanoscale vaccine technologies compared with clinically established conventional vaccines, and the lessons to be learnt from this potentially transformative development in the adoption and acceptance of nanotechnology for medicine.

    • Thomas Kisby
    • Açelya Yilmazer
    • Kostas Kostarelos
  • Sharing the step-by-step procedures necessary to fabricate nanostructures could optimize efforts to achieve reproducible devices.

    • Mohammad J. Bereyhi
    • Tobias J. Kippenberg
  • The FAIR principles provide compelling guidelines on how to achieve reusability of nanotechnology data.

  • The challenge of assessing the scope and magnitude of risk from nanomaterials is urgent for society and ignoring risks could be detrimental for development. This challenge is bigger than the individual capacities on each side of the Atlantic, but effective cross-Atlantic collaboration can solve essential riddles about the use of nanomaterials.

    • Janeck James Scott-Fordsmand
    • Mónica João de Barros Amorim
    • Christine Ogilvie Hendren
  • Research on nanoplastic has already provided some significant results but it has also exposed a large number of open questions.

When nanotechnology focuses on COVID-19

When nanotechnology focuses on COVID-19

In face of the coronavirus pandemic, the nanotechnology community has joined forces to provide tools and expertise to COVID-19 research efforts. Long-term experience in drug delivery, nanovaccines, immunoengineering, biosensors and platform technologies positions nanotechnology in a unique place to tackle some of the key issues in preclinical and clinical COVID-19 research

Nature Careers